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Table s1. The antibodies used for the immunoprecipitation and antibody array experiments.  
 
 
Table s2. Samples used in the pools. An internal ID number is used to indicate each unique 
sample used in each pool.  
 
 




Table s4. Mass-spectrometry results for the top four protein hits.  
 
 
Type Exp # N Unused Total %Cov (95) Accession Name Peptides(95%)
Exp#1 1 142 142 20 IPI:IPI00022229.1 APOB Apolipoprotein B-100 67
Exp#2 3 21 21 2 IPI:IPI00022229.1 APOB Apolipoprotein B-100 10
Exp#3 1 91.4 91.4 12.01 IPI:IPI00022229.1 APOB Apolipoprotein B-100 45
Exp#1 1 126 126 18 IPI:IPI00022229.1 APOB Apolipoprotein B-100 62
Exp#2 2 31 31 3 IPI:IPI00022229.1 APOB Apolipoprotein B-100 13
Exp#3 4 4.4 4.4 0.50 IPI:IPI00022229.1 APOB Apolipoprotein B-100 2
Exp#1 3 3 3 1 IPI:IPI00022229.1 APOB Apolipoprotein B-100 2
Exp#2 1 43 43 5 IPI:IPI00022229.1 APOB Apolipoprotein B-100 19
Exp#3 1 78.5 78.5 9.34 IPI:IPI00022229.1 APOB Apolipoprotein B-100 36
Exp#2 5 13 13 1 IPI:IPI00022229.1 APOB Apolipoprotein B-100 6












Table s5. Mass spectrometry identification of apolipoprotein B-100. 
 
